Clinical Focus

  • Residency
  • General Surgery

Honors & Awards

  • Scholar, Stanford Leadership Education in Advancing Diversity (LEAD) (2022-2023)
  • Scholar, Stanford Center for Innovation in Global Health (CIGH) Independent Scholars Program (2022)
  • Nominee, Kelley M. Skeff Graduate Medical Education Professionalism Award (2021-2022)
  • Recipient, Stanford Emergency Medicine Consultant of the Year Award (2021-2022)
  • Recipient, Samuel L. Kountz Humanitarian Award (2021-2022)
  • Recipient, Arnold P. Gold Humanism and Excellence in Teaching Award (2020-2021)
  • Recipient, Stanford General Surgery Consult Resident of the Year Award (2020-2021)
  • Recipient, Stanford General Surgery Resident Teaching Award (2019-2020)
  • Recipient, Stanford General Surgery Intern of the Year Award (2019-2020)
  • Honoree, Stanford Gold Humanism Honor Society (2018-2019)
  • Scholar, Mary Duke Biddle Clinical Scholars Program (2017-2018)
  • Fellow, Valley Foundation Fellowship (2016-2017)
  • Recipient, Outstanding Mentor of American Indian Students at Stanford (2016-2017)
  • Recipient, Stanford Medicine Outstanding Teaching Assistant Award (2016-2017)
  • Recipient, Kaiser Fellowship Fund Scholarship (2015-2018)

Boards, Advisory Committees, Professional Organizations

  • Member, American Academy of Hospice and Palliative Medicine (2023 - Present)
  • Academic Working Group, Food Tank (2022 - Present)
  • Member, Surgical Palliative Care Society (2022 - Present)
  • Member, Health Care Without Harm Physician Network (2022 - Present)
  • Resident Representative, Stanford Women in Medicine Leadership Council (2022 - Present)
  • Member, American College of Lifestyle Medicine (2020 - Present)
  • Resident Representative, Stanford Surgery J.E.D.I. (Justice, Equity, Diversity, Inclusion) Council (2020 - Present)
  • Member, American College of Surgeons (2019 - Present)
  • President (2016-2017), Member (2015-2019), Stanford School of Medicine Organization for Global Health (2015 - 2019)
  • President (2016-2017), Member (2015-2019), Stanford American Indigenous Medical Students (2015 - 2019)

Professional Education

  • MD, Stanford School of Medicine, Concentration in community and global health (2019)
  • Affiliate, Harvard School of Public Health, HIV Interventions: Rationale, Design, and Evaluation (2013)
  • BS, Cornell University, College of Human Ecology, Interdisciplinary studies in Human Biology, Health, and Society with a focus in nutritional sciences and global and community health (2013)
  • Visiting Scholar, University of Oxford, Human Sciences (2012)

Current Clinical Interests

  • General Surgery
  • Culinary Medicine
  • Underserved Populations
  • Diversity, Equity, Inclusion
  • Palliative Care
  • Global Health
  • Nutrition Sciences
  • Lifestyle Medicine
  • Public Health
  • Environmental Health

All Publications

  • Trends in the Inclusion of Black and Female Surgeons in Invited Visiting Professorships. JAMA surgery Tabata, M. M., Rosenthal, E. L., Arbaugh, C. J., Kin, C., Kim, E., Graham, L. A., Hawn, M. T. 2019

    View details for DOI 10.1001/jamasurg.2019.2137

    View details for PubMedID 31290945

  • Accuracy of the medication list in the electronic health record-implications for care, research, and improvement JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION Walsh, K. E., Marsolo, K. A., Davis, C., Todd, T., Martineau, B., Arbaugh, C., Verly, F., Samson, C., Margolis, P. 2018; 25 (7): 909-912


    Electronic medication lists may be useful in clinical decision support and research, but their accuracy is not well described. Our aim was to assess the completeness of the medication list compared to the clinical narrative in the electronic health record.We reviewed charts of 30 patients with inflammatory bowel disease (IBD) from each of 6 gastroenterology centers. Centers compared IBD medications from the medication list to the clinical narrative.We reviewed 379 IBD medications among 180 patients. There was variation by center, from 90% patients with complete agreement between the medication list and clinical narrative to 50% agreement.There was a range in the accuracy of the medication list compared to the clinical narrative. This information may be helpful for sites seeking to improve data quality and those seeking to use medication list data for research or clinical decision support.

    View details for DOI 10.1093/jamia/ocy027

    View details for Web of Science ID 000440954800019

    View details for PubMedID 29771350

    View details for PubMedCentralID PMC7647042

  • Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review PEDIATRIC CARDIOLOGY da Silva, T., Massetti, T., Crocetta, T., de Mello Monteiro, C., Carll, A., Marques Vanderlei, L., Arbaugh, C., Oliveira, F., de Abreu, L., Filho, C., Godleski, J., Ferreira, C. 2018; 39 (5): 869–83


    Duchenne muscular dystrophy (DMD) is a genetic recessive disorder with progressive muscle weakness. Despite the general muscle wasting, degeneration and necrosis of cardiomyocytes have been the main causes of morbidity and death in individuals with DMD. Cardiac failure is generally preceded by disturbances in heart rate variability (HRV), and non-invasive measurement of the autonomic nervous system has been an important tool to predict adverse cardiovascular events. Hence, the application of HRV to study autonomic modulation in DMD individuals, and the establishment of correlations between HRV and heart/lung diseases, age, and mortality will have the potential to improve quality of life and life expectancy of individuals with DMD. In order to evaluate the state of the art in this field, we conducted a systematic search in Medline/PubMed and BVS (virtual library in health) databases. We selected 8 studies using pre-defined criteria and meta-analysis revealed decreased parasympathetic activity and increased sympathetic predominance in individuals with DMD as major observations. Moreover, there is a strong association between diminished HRV and myocardial fibrosis with DMD. These patterns are evident in patients at early-stage DMD and become more prominent as disease severity and age increase. Thus, data minning clearly indicates that HRV assessment can be used as a predictor for sudden death in individuals with DMD. The use of the HRV, which is inexpensive, ubiquitously available in clinics and hospitals, and a non-invasive analysis tool, can save lives and decrease the morbity in DMD by alerting care givers to consider autonomic nervous system intervention.

    View details for PubMedID 29696428

  • Low socioeconomic status is associated with lower weight-loss outcomes 10-years after Roux-en-Y gastric bypass. Surgical endoscopy Carden, A. n., Blum, K. n., Arbaugh, C. J., Trickey, A. n., Eisenberg, D. n. 2018


    Roux-en-Y gastric bypass (RYGB) is the criterion standard operation for weight loss. Low socioeconomic status (SES) is common in the Veteran population undergoing bariatric surgery, but the impact of SES on long-term weight-loss outcomes is not known. We hypothesize that low socioeconomic status is associated with less weight loss after gastric bypass in long-term follow-up.We performed a retrospective review of patients undergoing RYGB at a single Veterans Affairs (VA) hospital. Patients with at least 10 years of follow-up data in the electronic health record were included in the analysis. Weight loss was measured as percent excess body mass index loss (%EBMIL). The primary predictor variable, median household income, was determined using zip codes of patient residences matched to publicly available 2010 U.S. census data. Univariate relationships between income, weight loss, and other patient characteristics were evaluated. We calculated a multivariate generalized linear model of %EBMIL to estimate independent relationships with median household income quartile while controlling for patients' age, race, sex, and VA distance.Complete 10-year follow-up data were available for 83 of 92 patients (90.2%) who underwent RYGB between 2001 and 2007 and survived at least 10 years. The majority of patients were male (79.5%) and white (73.5%). The mean 10-year %EBMIL was 57.8% (SD: 29.5%, range - 36.0% - 132.8%). In univariate analysis, income was significantly associated with race (p < 0.001) and median distance to the VA bariatric center (p = 0.034), but income did not differ by gender (p = 0.73) or age (p = 0.45). Multivariate analysis revealed significantly lower 10-year %EBMIL for patients with the lowest income compared to patients with low-mid income (p = 0.03) and mid-high income (p = 0.01), after controlling for gender, race, age, and VA distance.Low socioeconomic status is associated with lower weight-loss outcomes, 10 years after RYGB. Durable weight loss is observed in all income groups.

    View details for PubMedID 29987570